investorscraft@gmail.com

Intrinsic Value of Universal Health Services, Inc. (UHS)

Previous Close$184.53
Intrinsic Value
Upside potential
Previous Close
$184.53

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Universal Health Services, Inc. (UHS) operates as a leading healthcare management company, specializing in acute care hospitals, behavioral health facilities, and ambulatory centers across the U.S. and the U.K. The company generates revenue primarily through patient services, with a diversified portfolio catering to both physical and mental health needs. UHS distinguishes itself through a dual-platform strategy, balancing acute care and behavioral health services, which mitigates sector-specific risks and capitalizes on growing demand for mental health treatment. Its market position is reinforced by a network of over 400 facilities, ensuring broad geographic coverage and economies of scale. The behavioral health segment, in particular, benefits from long-term contracts and recurring revenue streams, providing stability amid fluctuating acute care volumes. UHS competes with large hospital chains and specialized providers but maintains an edge through operational efficiency and integrated care models. The company’s focus on high-margin services and strategic acquisitions further solidifies its standing in a fragmented but expanding healthcare market.

Revenue Profitability And Efficiency

UHS reported revenue of $15.8 billion for FY 2024, with net income of $1.14 billion, reflecting a net margin of approximately 7.2%. Diluted EPS stood at $16.82, demonstrating robust profitability. Operating cash flow of $2.07 billion underscores strong cash generation, though capital expenditures of $943.8 million indicate significant reinvestment needs. The company’s efficiency metrics suggest disciplined cost management, particularly in high-volume service lines.

Earnings Power And Capital Efficiency

The company’s earnings power is supported by stable demand for behavioral health services and selective acute care expansions. Return on invested capital remains healthy, driven by operational leverage and prudent capital allocation. UHS’s ability to generate consistent cash flow enables debt servicing and strategic investments, though its capital efficiency is tempered by high capex requirements for facility upgrades and expansions.

Balance Sheet And Financial Health

UHS maintains a leveraged balance sheet, with total debt of $4.96 billion against cash and equivalents of $126 million. The debt load reflects historical acquisitions and growth initiatives, but manageable interest coverage ratios suggest adequate liquidity. The company’s financial health is bolstered by predictable cash flows, though investors should monitor leverage ratios in light of potential interest rate volatility.

Growth Trends And Dividend Policy

Growth is driven by organic volume increases and targeted acquisitions, particularly in behavioral health. UHS pays a modest dividend of $0.80 per share, prioritizing reinvestment over shareholder payouts. The dividend yield remains low, aligning with the company’s focus on capital retention for expansion and debt reduction.

Valuation And Market Expectations

UHS trades at a P/E multiple reflective of its steady earnings profile and sector peers. Market expectations hinge on sustained demand for behavioral health services and margin stability in acute care. Valuation metrics suggest a balanced risk-reward profile, with upside tied to operational execution and regulatory tailwinds.

Strategic Advantages And Outlook

UHS benefits from its dual-service model, which diversifies revenue streams and reduces cyclical risks. The company is well-positioned to capitalize on rising mental health awareness and aging demographics. Near-term challenges include labor cost pressures and reimbursement dynamics, but long-term prospects remain favorable given its scalable platform and industry tailwinds.

Sources

10-K filings, company investor relations

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount